G. Lichtenstein

Hepatic Glutamine Synthetase Deficiency in Fatal Hyperammonemia after Lung Transplantation

M. Tuchman, J. Bavaria, G. Berry, 1997, Annals of Internal Medicine.

Fatal Hyperammonemia after Orthotopic Lung Transplantation

P. Kaplan, M. Tuchman, J. Bavaria, 2000, Annals of Internal Medicine.

Ischemic Colitis Associated with Factor V Leiden Mutation

D. Guerry, G. Lichtenstein, N. Yee, 2000, Annals of Internal Medicine.

Clinical and demographic characteristics predictive of treatment outcomes for certolizumab pegol in moderate to severe Crohn's disease: analyses from the 7‐year PRECiSE 3 study

Judy H. Cho, M. Regueiro, D. Schwartz, 2015, Alimentary pharmacology & therapeutics.

The Efficacy and Safety of Guselkumab Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Phase 2b QUASAR Study Results Through Week 12.

J. Panés, B. Bressler, J. Johanns, 2022, Gastroenterology & hepatology.

P518 Safety of upadacitinib in ulcerative colitis: Long-term data from the phase 3 open-label extension study (U-ACTIVATE)

R. Panaccione, A. Armuzzi, T. Kucharzik, 2023, Journal of Crohn's and Colitis.

Ischemic Colitis Associated with Decongestant Use

N. Yee, G. Lichtenstein, 2000, Annals of Internal Medicine.

Maintenance treatment with infliximab reduces hospitalizations and surgeries/procedures in patients with fistulizing Crohn?s Disease

G. Lichtenstein, 2002 .